Category

Daily Briefs

Daily Brief Thailand: Valeura Energy Inc and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Valeura Energy (TSX: VLE): Operational blip offers an opportunity for investors


Valeura Energy (TSX: VLE): Operational blip offers an opportunity for investors

By Auctus Advisors

  • 2Q24 production was 21.1 mbbl/d, which was very close to our expectations (21.3 mbbl/d).
  •  Production is expected to increase in 3Q24 with the start-up of production at Nong Yao C.
  • Half of the planned drilling targets have already been drilled.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Second Chance Properties and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Second Chance Properties (SCE SP): MSM Makes A Move
  • Second Chance Properties (SCE SP): Voluntary Unconditional Offer at S$0.30


Second Chance Properties (SCE SP): MSM Makes A Move

By David Blennerhassett

  • Founder/CEO Mohamed Salleh Maricar (MSM) and his family have made a voluntary unconditional general Offer for the 14.94% in gold/jewellery retailer Second Chance Properties (SCE SP) (“SCP”) not held.
  • The S$0.30/share cash Offer is a 39.5% premium to last close. The Offer price is final.
  • The Offer is unconditional in all respects. This will trade tight. A delisting Offer is next on the cards.

Second Chance Properties (SCE SP): Voluntary Unconditional Offer at S$0.30

By Arun George

  • Second Chance Properties (SCE SP) has disclosed a voluntary unconditional offer from Mohamed Salleh’s family at S$0.30 per share, a 39.5% premium to the undisturbed price (10 July).
  • The offer document will be despatched by 31 July. The offeree circular will be despatched by 7 August at the earliest, implying the earliest close of 28 August.
  • The offer price has been declared final and is attractive as it represents an all-time high. The offeror will likely achieve the 90% compulsory acquisition threshold.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Tesla , Gold, Applied Blockchain Inc, General Electric , Hunt (Jb) Transprt Svcs, Soybean Active Contract, Ipg Photonics, Aldeyra Therapeutics , Packaging Corporation of America, Five9 Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • Tesla Q2 Earnings Preview: All Eyes on China, Energy Storage, & Robotaxi
  • Is this the Death of Gold Developers?
  • An Interview with Wes Cummins, CEO of Applied Digital
  • General Electric Company: Is The Healthy Demand In Renewables Here To Stay? – Major Drivers
  • J.B. Hunt Transport Services: Expanded Intermodal Services Driving Our Bullish Thesis! – Major Drivers
  • [CB 27/2024] Wheat & Bean Up on Improving Demand as Corn Tumbles on Benign Planting & Solid Harvest
  • IPG Photonics Corporation: Expansion In The Electric Vehicle (EV) Market As A Key Growth Catalyst! – Major Drivers
  • Aldeyra Therapeutics Inc (ALDX) – Wednesday, Apr 10, 2024
  • Packaging Corporation of America: These Are The 6 Fundamental Factors Impacting Its Performance In 2024 & 2025! – Financial Forecasts
  • Five9 Inc.: Expansion into AI & Automation Solutions A Critical Growth Catalyst? – Major Drivers


Tesla Q2 Earnings Preview: All Eyes on China, Energy Storage, & Robotaxi

By Uttkarsh Kohli

  • Energy Growth: Tesla’s energy storage business surged to 9.4 GWh in Q2, a 135% increase from Q1’s 4 GWh.
  • China’s Impact: Shanghai Gigafactory shipments fell 24.2% YoY in June, delivering 71,007 units amid a Chinese price war.
  • FSD & Robotaxi: Full Self-Driving price cut to $8,000 from $15,000; investors await Robotaxi Day on 8/8.

Is this the Death of Gold Developers?

By Money of Mine

  • WA gold explorers and developers are struggling in the market compared to producers
  • Value gap between explorers/developers and producers has widened, with little progress in projects
  • Cash balances are dwindling for many companies, raising questions for investors about the incentive to fund them

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


An Interview with Wes Cummins, CEO of Applied Digital

By Douglas O’Laughlin

  • Doug O’Laughlin: Today, on Fabricated Knowledge, I have the privilege of having Wes from Applied Digital on to talk about Applied Digital.
  • Today, we’re gonna talk about the change in his business model. The company is experiencing a lot of changes, and there are a lot of new things in the pipeline.
  • And so I just wanted to sit him down and have an opportunity to chat about that. 

General Electric Company: Is The Healthy Demand In Renewables Here To Stay? – Major Drivers

By Baptista Research

  • General Electric Company, known as GE, recently marked a significant milestone by completing the spin-off of GE Vernova and launching GE Aerospace, positioning the company as a focused leader in the aerospace and defense industry.
  • This transition follows the successful spin-off of GE Healthcare last year, achieving a strategic restructuring aimed at strengthening the company’s core operations and financial health.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

J.B. Hunt Transport Services: Expanded Intermodal Services Driving Our Bullish Thesis! – Major Drivers

By Baptista Research

  • J.B. Hunt Transport Services, Inc. presented its First Quarter 2024 results delineating challenges primarily driven by continued market pressures, alongside optimistic notes on strategic positioning and long-term growth.
  • The results highlighted a decline in revenues and profits, accentuated by inflationary pressures intermingling with deflationary pricing dynamics, reflecting the intricate operational environment the company navigates.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

[CB 27/2024] Wheat & Bean Up on Improving Demand as Corn Tumbles on Benign Planting & Solid Harvest

By Srinidhi Raghavendra

  • Recent acreage report shows benign planting figures and solid ending stocks for Corn sending its prices lower. Wheat also declined on higher stocks, while Soybeans rebounded.
  • Wheat faces headwinds & tailwinds. Fundamentals are dragged down by favorable weather in exporting countries & imminent US harvest; Strong US demand & weak EU forecast has supported prices.
  • Soybeans appear well supported from an unlikely ally in Trump. Import Duty tit-for-tat could see China slapping duty on Soy imports.

IPG Photonics Corporation: Expansion In The Electric Vehicle (EV) Market As A Key Growth Catalyst! – Major Drivers

By Baptista Research

  • IPG Photonics’ first quarter of 2024 financial results and business updates reflect a mix of challenges and strategic advancements amid an evolving market landscape.
  • The company, a leader in high-performance fiber lasers and amplifiers, reported a decline in revenue, largely attributed to softening demand in key industrial sectors, particularly e-mobility and general industrial manufacturing.
  • These sectors represent a significant portion of IPG Photonics’ sales, translating revenue impacts across various applications.

Aldeyra Therapeutics Inc (ALDX) – Wednesday, Apr 10, 2024

By Value Investors Club

  • Mack885 identified buying opportunity in ALDX due to management’s plan to address FDA setback
  • Perceptive Advisors increased stake in anticipation of reproxalap approval for dry eye disease
  • Potential option agreement with AbbVie could greatly benefit ALDX financially, making its share price undervalued

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Packaging Corporation of America: These Are The 6 Fundamental Factors Impacting Its Performance In 2024 & 2025! – Financial Forecasts

By Baptista Research

  • Packaging Corporation of America reported its first quarter 2024 results, including a net income of $155 million, or $1.72 per share, and a total net sales of $2 billion.
  • While these figures show a decrease from first quarter 2023 results of $198 million net income, or $2.20 per share, and the same $2 billion net sales, they still mark a significant achievement for the company.
  • To tackle inflation, Packaging Corporation of America has been focusing on cost management and improving process efficiencies across its manufacturing and converting facilities.

Five9 Inc.: Expansion into AI & Automation Solutions A Critical Growth Catalyst? – Major Drivers

By Baptista Research

  • Five9’s recent financial recap underscores its robust position in the cloud-based contact center market, highlighted by a notable 20% year-over-year growth in subscription revenues and a total revenue surpassing guidance expectations.
  • These achievements are particularly significant because they underscore organic growth without contributions from transitioning customers from on-premise to cloud solutions, distinguishing Five9 as purely cloud-focused in its operations.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Linklogis, Hong Kong Television Network, The United Laboratories International Holdings Limited, B&K Corporation, Lenovo and more

By | China, Daily Briefs

In today’s briefing:

  • Hang Seng Internet & IT Index (HSIII) Rebalance Preview: Three Adds/Deletes & Capping Changes
  • HKTV (1137 HK): HK$2.15 Share Buyback Is Unconditional
  • The United Laboratories Company Ltd (3933 HK) – A Sub Five PE Bargain!
  • Pre-IPO B&K Corporation – Valuation Performance Could Be Disappointing
  • Morning Views Asia: Lenovo


Hang Seng Internet & IT Index (HSIII) Rebalance Preview: Three Adds/Deletes & Capping Changes

By Brian Freitas

  • The review cutoff date for the September rebalance of the HSIII was 28 June. The changes will be announced on 16 August and become effective after the close 6 September.
  • There could be 3 changes to the index with some inclusions driven by potential addition to the Hang Seng Composite Index. That could lead to buying via Southbound Stock Connect.
  • Capping will result in passives buying Kuaishou Technology (1024 HK) and JD.com (9618 HK) while selling Meituan (3690 HK) and Tencent (700 HK).

HKTV (1137 HK): HK$2.15 Share Buyback Is Unconditional

By Arun George

  • The Hong Kong Television Network (1137 HK) vote on the share buyback for a maximum of 100.0m or 11.25% of outstanding shares at HK$2.15 was comfortably passed at the EGM.
  • The partial offer is designed to help the co-founders bypass the creeper rule and increase their grip on the shares. There is no minimum acceptance condition. 
  • While the IFA opines the offer is fair and reasonable, it is unattractive. A 100% minority participation rate implies a minimum proration of 20.74%. The offer closes on 23 July.  

The United Laboratories Company Ltd (3933 HK) – A Sub Five PE Bargain!

By Avien Pillay

  • At a 4.6 FPE, you would expect to find some real concerns, however there are no gremlins anywhere?  
  • What you are buying is an antibiotic developer and distributor who is performing better than expected, given that the antibiotic market is thriving.
  • The extensive pipeline including GLP-1 drugs is still at an early stage/midway through development, however at this valuation, you are probably not paying for it!

Pre-IPO B&K Corporation – Valuation Performance Could Be Disappointing

By Xinyao (Criss) Wang

  • The growth factor drug market is highly competitive. Many competing products have been on the market for many years with NRDL reimbursement coverage and also accumulated rich recognition from doctors/patients.
  • Even if Pro-101 is approved for market launch, B&K may have to reduce its price largely and invest heavily in market education/promotion. B&K’s commercialization capability still needs to be verified.
  • Valuation of B&K would be lower than peers. It is hard for B&K to receive expected valuation premium since its latest round of post investment valuation is already RMB3.3 billion.

Morning Views Asia: Lenovo

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Kokusai Electric , Timee Inc, Creek & River, Shift Inc and more

By | Daily Briefs, Japan

In today’s briefing:

  • Kokusai Elec (6525) ¥300bn+ Offering at ATH – Almost a Second IPO
  • Kokusai Electric (6525 JP): Placement, Buyback & Index Flows
  • Kokusai Electric (6525 JP): A US$2.0 Billion Secondary Offering
  • Kokusai Electric Placement – US$1.7bn Selldown for a Good Quality Name
  • Timee IPO: Strong Business Model with Improving Financials
  • Creek & River (4763 JP): Q1 FY02/25 flash update
  • Shift Inc (3697 JP): Q3 FY08/24 flash update


Kokusai Elec (6525) ¥300bn+ Offering at ATH – Almost a Second IPO

By Travis Lundy

  • Today post-close we got confirmation of yesterday’s Reuters scoop of a secondary selldown on Kokusai Electric (6525 JP) after the stock fell 7.2% in heavy volume.
  • KKR HKE LP and KSP Kokusai LLC (Koch) will together sell 52.5mm shares plus another 7.8mm+ in the greenshoe. Split is 50/50 domestic/international. 
  • This is 60+mm shares against 51mm shares held by non-passive holders ex-Capital (who has been selling). It’s a lot of stock at a high price.

Kokusai Electric (6525 JP): Placement, Buyback & Index Flows

By Brian Freitas

  • KKR and KSP Kokusai will offer 52.51m-60.38m shares (US$1.76bn-2bn) of Kokusai Electric (6525 JP) in a secondary offering that will likely be priced on 22 July.
  • Kokusai Electric (6525 JP) will also buy back up to JPY 18bn of its shares. At the last close, that is 3.33m shares (1.2x ADV).
  • Trackers of one global index will buy stock at the time of settlement of the shares. The (much) bigger buying will come at the end of August.

Kokusai Electric (6525 JP): A US$2.0 Billion Secondary Offering

By Arun George

  • Kokusai Electric (6525 JP) has announced a secondary offering of up to 60.4 million shares (including overallotment). At the close, the offer, including overallotment, is worth JPY326 billion (US$2.0 billion).
  • The secondary offering facilitates KKR and KSP Kokusai Investments’ ability to crystallise substantial IPO gains—the shares are trading at 3.2x the IPO price of JPY1,840.
  • Looking at recent large Japanese placements is instructive for understanding the potential offer price. The pricing date will fall between 22 and 24 July (likely 22 July).

Kokusai Electric Placement – US$1.7bn Selldown for a Good Quality Name

By Ethan Aw

  • KKR & Co (KKR US) and KSP Kokusai Investments are looking to raise approximately US$1.7bn through an extended secondary follow-on offering, selling approximately 52.5m shares of Kokusai Electric (6525 JP)’s stock.
  • The deal is a large one to digest at 19 days of three month ADV.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Timee IPO: Strong Business Model with Improving Financials

By Shifara Samsudeen, ACMA, CGMA

  • Timee Inc (215A JP)  operates an on-demand job platform in Japan and the company has filed for an IPO where existing shareholders will offer shares worth of $290m.
  • The company’s top line saw accelerated growth during last 4-5 years driven by increase in no. of clients/workers while Timee also has turned around its profitability during the last 2-years.
  • In this insight, we have discussed the company’s business model and financials in detail and we will discuss our forecasts and valuation in a follow-up insight.

Creek & River (4763 JP): Q1 FY02/25 flash update

By Shared Research

  • Sales increased by JPY108mn (+0.8% YoY), driven by growth in Creative (Japan), Accounting and Legal, and Other sectors.
  • Operating profit decreased by JPY318mn (-20.2% YoY), mainly due to reduced profits in Creative (Japan) and Medical Staffing.
  • Sales and operating profit decreased YoY due to reduced COVID-19 vaccination projects and structural reforms in Medical Principle.

Shift Inc (3697 JP): Q3 FY08/24 flash update

By Shared Research

  • In cumulative Q3 FY08/24, the company reported sales of JPY81.1bn (+28.1% YoY) and net income of JPY3.3bn (-17.2% YoY).
  • Q3 GPM was 31.7%, with the Software Testing segment reporting JPY52.4bn in sales and JPY17.5bn in gross profit.
  • Software Development segment sales were JPY25.7bn (+33.6% YoY), while operating profit declined due to lower utilization at subsidiaries.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Timee Inc, Doosan Enerbility, General Electric , Hunt (Jb) Transprt Svcs, Gol Linhas Aereas Intel-Adr, Urban-Gro , FuelCell Energy , Creek & River and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Timee IPO: Strong Business Model with Improving Financials
  • Doosan Enerbility: A Key Beneficiary of Potential Nuclear Power Projects Win in the Czech Republic
  • General Electric Company: Is The Healthy Demand In Renewables Here To Stay? – Major Drivers
  • J.B. Hunt Transport Services: Expanded Intermodal Services Driving Our Bullish Thesis! – Major Drivers
  • GOL – Short-Term Challenges to Navigate Before Delivering on Complicated Long-Term Pitch
  • UGRO; 2H Signposts: Leaving the CEA Wilderness?; Reiterate Buy, $8 PT
  • FuelCell Energy Inc.: Can It Capitalize On The Emerging Market Opportunities in Small to Mid-Scale Carbon Capture? – Major Drivers
  • Creek & River (4763 JP): Q1 FY02/25 flash update


Timee IPO: Strong Business Model with Improving Financials

By Shifara Samsudeen, ACMA, CGMA

  • Timee Inc (215A JP)  operates an on-demand job platform in Japan and the company has filed for an IPO where existing shareholders will offer shares worth of $290m.
  • The company’s top line saw accelerated growth during last 4-5 years driven by increase in no. of clients/workers while Timee also has turned around its profitability during the last 2-years.
  • In this insight, we have discussed the company’s business model and financials in detail and we will discuss our forecasts and valuation in a follow-up insight.

Doosan Enerbility: A Key Beneficiary of Potential Nuclear Power Projects Win in the Czech Republic

By Douglas Kim

  • The Czech Republic government is in the final stages of selecting companies to build four nuclear power plants which could cost nearly US$30 billion.
  • A Korean consortium including KHNP, Doosan Enerbility, KEPCO E&C, and Daewoo E&C is competing mainly against EDF, a French government owned electric utility company. 
  • If the KHNP consortium is able to win this new order, Doosan Enerbility will be a key beneficiary as it will supply the nuclear reactors and steam generators.

General Electric Company: Is The Healthy Demand In Renewables Here To Stay? – Major Drivers

By Baptista Research

  • General Electric Company, known as GE, recently marked a significant milestone by completing the spin-off of GE Vernova and launching GE Aerospace, positioning the company as a focused leader in the aerospace and defense industry.
  • This transition follows the successful spin-off of GE Healthcare last year, achieving a strategic restructuring aimed at strengthening the company’s core operations and financial health.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

J.B. Hunt Transport Services: Expanded Intermodal Services Driving Our Bullish Thesis! – Major Drivers

By Baptista Research

  • J.B. Hunt Transport Services, Inc. presented its First Quarter 2024 results delineating challenges primarily driven by continued market pressures, alongside optimistic notes on strategic positioning and long-term growth.
  • The results highlighted a decline in revenues and profits, accentuated by inflationary pressures intermingling with deflationary pricing dynamics, reflecting the intricate operational environment the company navigates.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

GOL – Short-Term Challenges to Navigate Before Delivering on Complicated Long-Term Pitch

By Neil Glynn

  • We cut our 2024 EBITDAR by 19% following a disappointing May revenue performance at GOL.
  • We also emphasise that plans to double 2023 EBITDAR by 2029 are highly ambitious in the context of Brazilian competitors LATAM and Azul margin progress since 2019.
  • GOL, undergoing Chapter 11, is the subject of much consolidation focus with an Azul codeshare and parent Abra discussing combining GOL with Azul. Leverage plans render effective consolidation more difficult. 

UGRO; 2H Signposts: Leaving the CEA Wilderness?; Reiterate Buy, $8 PT

By Small Cap Consumer Research

  • We are reiterating our Buy recommendation, $8 price target and projections as we look at key trends for 2H2024 and beyond for urban-gro.
  • Given the increase in Controlled Environment Agriculture (“CEA”) contract momentum, the pending reclassification from a Schedule I to a Schedule III drug for marijuana, the potential for Florida to legalize recreational cannabis on Election Day, and what we believe has been continued demand for commercial services, we believe the potential for top and bottom line upside for the company has continued to increase.
  • That said, we have, given urban-gro’s prior history and the current valuation, remained conservative in our projections.

FuelCell Energy Inc.: Can It Capitalize On The Emerging Market Opportunities in Small to Mid-Scale Carbon Capture? – Major Drivers

By Baptista Research

  • FuelCell Energy, a global leader in delivering fuel cell power solutions, reported its financial results for the second quarter of fiscal year 2024.
  • The company is recognized for its innovative technologies that contribute to a sustainable environment, such as carbon-neutral power generation and hydrogen production.
  • However, the recent earnings exhibits both robust achievements and certain challenges that are integral for stakeholders to consider.

Creek & River (4763 JP): Q1 FY02/25 flash update

By Shared Research

  • Sales increased by JPY108mn (+0.8% YoY), driven by growth in Creative (Japan), Accounting and Legal, and Other sectors.
  • Operating profit decreased by JPY318mn (-20.2% YoY), mainly due to reduced profits in Creative (Japan) and Medical Staffing.
  • Sales and operating profit decreased YoY due to reduced COVID-19 vaccination projects and structural reforms in Medical Principle.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Gold, Entree Resources, Packaging Corporation of America, Valeura Energy Inc, Pulsar Helium, Ring Energy Inc, Sealed Air Corp, Kolibri Global Energy , Fmc Corp, Forum Energy Technologies and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Is this the Death of Gold Developers?
  • Mongolia Elections Behind Us and Rio Versus Entree Arbitration Ruling Expected by Late 3Q24
  • Packaging Corporation of America: These Are The 6 Fundamental Factors Impacting Its Performance In 2024 & 2025! – Financial Forecasts
  • Valeura Energy (TSX: VLE): Operational blip offers an opportunity for investors
  • Pulsar Helium Inc. – D Seismic Confirms Resources and Highlights Deeper Helium Potential
  • Ring Energy, Inc. – Capital Program and Efficiency Gains Contributing to Production Outperformance
  • Sealed Air Corporation: Increasing Automation & Partnership Collaborations Driving Top-Line Growth? – Major Drivers
  • Kolibri Global Energy – New approach to drilling; potential share buyback
  • FMC Corporation: Enhanced Agrochemical Demand in Latin America Driving Our Optimism? – Major Drivers
  • Forum Energy Technologies, Inc. – Estimate Update


Is this the Death of Gold Developers?

By Money of Mine

  • WA gold explorers and developers are struggling in the market compared to producers
  • Value gap between explorers/developers and producers has widened, with little progress in projects
  • Cash balances are dwindling for many companies, raising questions for investors about the incentive to fund them

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Mongolia Elections Behind Us and Rio Versus Entree Arbitration Ruling Expected by Late 3Q24

By Nicolas Van Broekhoven

  • Entree Resources (ETG CN) has been in an arbitration proceeding against Rio Tinto PLC (RIO LN) since April 2024.
  • After initial hearings earlier in 1H24 we expect final arguments next week. The arbitration committee verdict should come by late 3Q24.
  • At stake is the relationship and ownership arrangement between ETG and RIO’s in Oyu Tolgoi, one of the world’s largest copper mines. Just concluded Mongolian elections clear the last hurdle.

Packaging Corporation of America: These Are The 6 Fundamental Factors Impacting Its Performance In 2024 & 2025! – Financial Forecasts

By Baptista Research

  • Packaging Corporation of America reported its first quarter 2024 results, including a net income of $155 million, or $1.72 per share, and a total net sales of $2 billion.
  • While these figures show a decrease from first quarter 2023 results of $198 million net income, or $2.20 per share, and the same $2 billion net sales, they still mark a significant achievement for the company.
  • To tackle inflation, Packaging Corporation of America has been focusing on cost management and improving process efficiencies across its manufacturing and converting facilities.

Valeura Energy (TSX: VLE): Operational blip offers an opportunity for investors

By Auctus Advisors

  • 2Q24 production was 21.1 mbbl/d, which was very close to our expectations (21.3 mbbl/d).
  •  Production is expected to increase in 3Q24 with the start-up of production at Nong Yao C.
  • Half of the planned drilling targets have already been drilled.

Pulsar Helium Inc. – D Seismic Confirms Resources and Highlights Deeper Helium Potential

By Auctus Advisors

  • The initial 1.1 km 2D seismic sweep survey shows a seismic reflector at the same depth where gas was intersected at the Jetstream #1 well.
  • This is important as it supports the contingent resources estimated in the Competent Persons Report published at the time of the IPO.
  • These resources had been estimated with limited reservoir and seismic data.

Ring Energy, Inc. – Capital Program and Efficiency Gains Contributing to Production Outperformance

By Water Tower Research

  • On July 8, 2024, Ring increased its 2Q24 production guidance to 13.5-13.7 MB/d of oil (19.5-19.7 MBOE/d) from 13.0-13.4 MB/d of oil (18.5-19.1 MBOE/d) reflecting the continuation of outperformance exhibited in 1Q24 (Figure 1).
  • Production volumes are benefiting from outperformance in Ring’s development program and increased operational efficiencies in the company’s base production.
  • The midpoint reflects gains of ~2% Q/Q and 15% Y/Y. The Y/Y gain partially reflects the addition of assets acquired in the Central Basin Platform from August 2023.

Sealed Air Corporation: Increasing Automation & Partnership Collaborations Driving Top-Line Growth? – Major Drivers

By Baptista Research

  • Sealed Air Corporation has disclosed its financial outcomes for the first quarter of 2024, presenting mixed results amid shifting market conditions and ongoing strategic adjustments.
  • Revenue for the quarter reached $1.33 billion with an adjusted EBITDA of $278 million, indicating robust performance despite the challenging dynamics, particularly in the Protective segment.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Kolibri Global Energy – New approach to drilling; potential share buyback

By Edison Investment Research

Kolibri Global Energy (KEI) has provided an update on operations and revised guidance. It now guides to FY24 revenue of US$57–62m and EBITDA of US$43–48m on average production of 3,200–3,700boepd. KEI plans to start drilling its next three wells in the first half of August. These wells will have longer lateral lengths, which should result in better well economics. We have revised our estimates to reflect the latest guidance and operational update. Our valuation of KEI falls slightly to US$6.8/share. The announced intention to initiate a share buyback, as well as the recent inclusion in the Russell Microcap Index, should provide additional support to the shares.


FMC Corporation: Enhanced Agrochemical Demand in Latin America Driving Our Optimism? – Major Drivers

By Baptista Research

  • FMC Corporation delivered mixed first-quarter results for 2024, characterized by solid EBITDA that met the higher end of the company’s guidance and significant improvement in cash flow, yet facing a notable decline in revenue and volume.
  • During this period, revenue decreased by 32% compared to the previous year, with a 27% drop in volume primarily attributable to ongoing channel destocking and delayed purchasing behavior by growers, aligning with the trend observed over the past year.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Forum Energy Technologies, Inc. – Estimate Update

By Water Tower Research

  • We are updating our estimates to reflect higher expected interest expense in 2Q24.
  • On the May 3, 2024, earnings call to discuss 1Q24 results, management indicated that 2Q24 interest expense would be ~$8 million.
  • Our previously published 2Q24 interest expense estimate was $7.1 million. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Kokusai Electric , Wiwynn Corp, Taiwan Semiconductor (TSMC) – ADR, Linklogis, Shift Up, Applied Blockchain Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Kokusai Elec (6525) ¥300bn+ Offering at ATH – Almost a Second IPO
  • Kokusai Electric (6525 JP): Placement, Buyback & Index Flows
  • Wiwynn GDR Offering – US$1.45bn Dilutive Offering, but Momentum Has Been Very Strong
  • Kokusai Electric (6525 JP): A US$2.0 Billion Secondary Offering
  • Taiwan Tech Weekly: TSMC Sales Beat High Expectations; Wiwynn GDR Offering; IPhone 17 to Use 2nm
  • Hang Seng Internet & IT Index (HSIII) Rebalance Preview: Three Adds/Deletes & Capping Changes
  • Trading Strategy of Shift Up on the First Day of IPO
  • Taiwan Dual-Listings Monitor: TSMC Spread on Brink of Falling to Past Levels; UMC Extreme Premium
  • Kokusai Electric Placement – US$1.7bn Selldown for a Good Quality Name
  • An Interview with Wes Cummins, CEO of Applied Digital


Kokusai Elec (6525) ¥300bn+ Offering at ATH – Almost a Second IPO

By Travis Lundy

  • Today post-close we got confirmation of yesterday’s Reuters scoop of a secondary selldown on Kokusai Electric (6525 JP) after the stock fell 7.2% in heavy volume.
  • KKR HKE LP and KSP Kokusai LLC (Koch) will together sell 52.5mm shares plus another 7.8mm+ in the greenshoe. Split is 50/50 domestic/international. 
  • This is 60+mm shares against 51mm shares held by non-passive holders ex-Capital (who has been selling). It’s a lot of stock at a high price.

Kokusai Electric (6525 JP): Placement, Buyback & Index Flows

By Brian Freitas

  • KKR and KSP Kokusai will offer 52.51m-60.38m shares (US$1.76bn-2bn) of Kokusai Electric (6525 JP) in a secondary offering that will likely be priced on 22 July.
  • Kokusai Electric (6525 JP) will also buy back up to JPY 18bn of its shares. At the last close, that is 3.33m shares (1.2x ADV).
  • Trackers of one global index will buy stock at the time of settlement of the shares. The (much) bigger buying will come at the end of August.

Wiwynn GDR Offering – US$1.45bn Dilutive Offering, but Momentum Has Been Very Strong

By Clarence Chu

  • Wiwynn Corp (6669 TT) is looking to raise around US$850m in its global depository receipts (GDRs) offering.
  • Similar to previous GDR listings, the deal is a long drawn out process with the firm required to jump through a number of board/shareholder/regulatory approval loops.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Kokusai Electric (6525 JP): A US$2.0 Billion Secondary Offering

By Arun George

  • Kokusai Electric (6525 JP) has announced a secondary offering of up to 60.4 million shares (including overallotment). At the close, the offer, including overallotment, is worth JPY326 billion (US$2.0 billion).
  • The secondary offering facilitates KKR and KSP Kokusai Investments’ ability to crystallise substantial IPO gains—the shares are trading at 3.2x the IPO price of JPY1,840.
  • Looking at recent large Japanese placements is instructive for understanding the potential offer price. The pricing date will fall between 22 and 24 July (likely 22 July).

Taiwan Tech Weekly: TSMC Sales Beat High Expectations; Wiwynn GDR Offering; IPhone 17 to Use 2nm

By Vincent Fernando, CFA

  • TSMC June Sales Surge Higher Than Expectations; Apple Will Be Use TSMC’s 2nm Node for Next Year’s iPhone 17
  • Wiwynn GDR Offering – US$1.45bn Dilutive Offering, but Momentum Has Been Very Strong 
  • Silergy (6415.TT): Trial-Run with Vanguard, and Recent Stock Drops Represent an Entry Opportunity. 

Hang Seng Internet & IT Index (HSIII) Rebalance Preview: Three Adds/Deletes & Capping Changes

By Brian Freitas

  • The review cutoff date for the September rebalance of the HSIII was 28 June. The changes will be announced on 16 August and become effective after the close 6 September.
  • There could be 3 changes to the index with some inclusions driven by potential addition to the Hang Seng Composite Index. That could lead to buying via Southbound Stock Connect.
  • Capping will result in passives buying Kuaishou Technology (1024 HK) and JD.com (9618 HK) while selling Meituan (3690 HK) and Tencent (700 HK).

Trading Strategy of Shift Up on the First Day of IPO

By Douglas Kim

  • In this insight, we discuss a trading strategy for Shift Up which starts trading on 11 July. Shift Up is one of the most anticipated IPOs in Korea this year.
  • Our base case (6 months – 1 year) target price of Shift Up is 95,510 won, which is 59% higher than the IPO price.
  • We recommend investors to take some profits (about 50% of invested capital) if the share price shoots higher by 100% or more from the IPO price on the first day.

Taiwan Dual-Listings Monitor: TSMC Spread on Brink of Falling to Past Levels; UMC Extreme Premium

By Vincent Fernando, CFA

  • TSMC: +15.1% Premium; Will It Break Down to Lower Past Trading Levels?
  • UMC: +2.4% Premium; Can Consider Shorting This Historically High Level
  • ChipMOS: -3.1% Discount; Long The Spread Given Historically Extreme Discount

Kokusai Electric Placement – US$1.7bn Selldown for a Good Quality Name

By Ethan Aw

  • KKR & Co (KKR US) and KSP Kokusai Investments are looking to raise approximately US$1.7bn through an extended secondary follow-on offering, selling approximately 52.5m shares of Kokusai Electric (6525 JP)’s stock.
  • The deal is a large one to digest at 19 days of three month ADV.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

An Interview with Wes Cummins, CEO of Applied Digital

By Douglas O’Laughlin

  • Doug O’Laughlin: Today, on Fabricated Knowledge, I have the privilege of having Wes from Applied Digital on to talk about Applied Digital.
  • Today, we’re gonna talk about the change in his business model. The company is experiencing a lot of changes, and there are a lot of new things in the pipeline.
  • And so I just wanted to sit him down and have an opportunity to chat about that. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Timee Inc, Doosan Enerbility, General Electric , Hunt (Jb) Transprt Svcs, Gol Linhas Aereas Intel-Adr, Urban-Gro , FuelCell Energy , Creek & River and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Timee IPO: Strong Business Model with Improving Financials
  • Doosan Enerbility: A Key Beneficiary of Potential Nuclear Power Projects Win in the Czech Republic
  • General Electric Company: Is The Healthy Demand In Renewables Here To Stay? – Major Drivers
  • J.B. Hunt Transport Services: Expanded Intermodal Services Driving Our Bullish Thesis! – Major Drivers
  • GOL – Short-Term Challenges to Navigate Before Delivering on Complicated Long-Term Pitch
  • UGRO; 2H Signposts: Leaving the CEA Wilderness?; Reiterate Buy, $8 PT
  • FuelCell Energy Inc.: Can It Capitalize On The Emerging Market Opportunities in Small to Mid-Scale Carbon Capture? – Major Drivers
  • Creek & River (4763 JP): Q1 FY02/25 flash update


Timee IPO: Strong Business Model with Improving Financials

By Shifara Samsudeen, ACMA, CGMA

  • Timee Inc (215A JP)  operates an on-demand job platform in Japan and the company has filed for an IPO where existing shareholders will offer shares worth of $290m.
  • The company’s top line saw accelerated growth during last 4-5 years driven by increase in no. of clients/workers while Timee also has turned around its profitability during the last 2-years.
  • In this insight, we have discussed the company’s business model and financials in detail and we will discuss our forecasts and valuation in a follow-up insight.

Doosan Enerbility: A Key Beneficiary of Potential Nuclear Power Projects Win in the Czech Republic

By Douglas Kim

  • The Czech Republic government is in the final stages of selecting companies to build four nuclear power plants which could cost nearly US$30 billion.
  • A Korean consortium including KHNP, Doosan Enerbility, KEPCO E&C, and Daewoo E&C is competing mainly against EDF, a French government owned electric utility company. 
  • If the KHNP consortium is able to win this new order, Doosan Enerbility will be a key beneficiary as it will supply the nuclear reactors and steam generators.

General Electric Company: Is The Healthy Demand In Renewables Here To Stay? – Major Drivers

By Baptista Research

  • General Electric Company, known as GE, recently marked a significant milestone by completing the spin-off of GE Vernova and launching GE Aerospace, positioning the company as a focused leader in the aerospace and defense industry.
  • This transition follows the successful spin-off of GE Healthcare last year, achieving a strategic restructuring aimed at strengthening the company’s core operations and financial health.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

J.B. Hunt Transport Services: Expanded Intermodal Services Driving Our Bullish Thesis! – Major Drivers

By Baptista Research

  • J.B. Hunt Transport Services, Inc. presented its First Quarter 2024 results delineating challenges primarily driven by continued market pressures, alongside optimistic notes on strategic positioning and long-term growth.
  • The results highlighted a decline in revenues and profits, accentuated by inflationary pressures intermingling with deflationary pricing dynamics, reflecting the intricate operational environment the company navigates.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

GOL – Short-Term Challenges to Navigate Before Delivering on Complicated Long-Term Pitch

By Neil Glynn

  • We cut our 2024 EBITDAR by 19% following a disappointing May revenue performance at GOL.
  • We also emphasise that plans to double 2023 EBITDAR by 2029 are highly ambitious in the context of Brazilian competitors LATAM and Azul margin progress since 2019.
  • GOL, undergoing Chapter 11, is the subject of much consolidation focus with an Azul codeshare and parent Abra discussing combining GOL with Azul. Leverage plans render effective consolidation more difficult. 

UGRO; 2H Signposts: Leaving the CEA Wilderness?; Reiterate Buy, $8 PT

By Small Cap Consumer Research

  • We are reiterating our Buy recommendation, $8 price target and projections as we look at key trends for 2H2024 and beyond for urban-gro.
  • Given the increase in Controlled Environment Agriculture (“CEA”) contract momentum, the pending reclassification from a Schedule I to a Schedule III drug for marijuana, the potential for Florida to legalize recreational cannabis on Election Day, and what we believe has been continued demand for commercial services, we believe the potential for top and bottom line upside for the company has continued to increase.
  • That said, we have, given urban-gro’s prior history and the current valuation, remained conservative in our projections.

FuelCell Energy Inc.: Can It Capitalize On The Emerging Market Opportunities in Small to Mid-Scale Carbon Capture? – Major Drivers

By Baptista Research

  • FuelCell Energy, a global leader in delivering fuel cell power solutions, reported its financial results for the second quarter of fiscal year 2024.
  • The company is recognized for its innovative technologies that contribute to a sustainable environment, such as carbon-neutral power generation and hydrogen production.
  • However, the recent earnings exhibits both robust achievements and certain challenges that are integral for stakeholders to consider.

Creek & River (4763 JP): Q1 FY02/25 flash update

By Shared Research

  • Sales increased by JPY108mn (+0.8% YoY), driven by growth in Creative (Japan), Accounting and Legal, and Other sectors.
  • Operating profit decreased by JPY318mn (-20.2% YoY), mainly due to reduced profits in Creative (Japan) and Medical Staffing.
  • Sales and operating profit decreased YoY due to reduced COVID-19 vaccination projects and structural reforms in Medical Principle.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: The United Laboratories International Holdings Limited, B&K Corporation, Aldeyra Therapeutics , Soligenix , BrainStorm Cell Therapeutics I, AFT Pharmaceuticals, Immix Biopharma Inc and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • The United Laboratories Company Ltd (3933 HK) – A Sub Five PE Bargain!
  • Pre-IPO B&K Corporation – Valuation Performance Could Be Disappointing
  • Aldeyra Therapeutics Inc (ALDX) – Wednesday, Apr 10, 2024
  • SNGX: Positive Interim Results for HyBryte in Investigator-Initiated Study in CTCL Raising Valuation to 35
  • BCLI: Preparing to Initiate Phase 3b Trial of NurOwn Before End of 2024
  • AFT Pharmaceuticals – Continued execution of footprint expansion
  • Immix Biopharma – US CAR-T trial commences patient dosing


The United Laboratories Company Ltd (3933 HK) – A Sub Five PE Bargain!

By Avien Pillay

  • At a 4.6 FPE, you would expect to find some real concerns, however there are no gremlins anywhere?  
  • What you are buying is an antibiotic developer and distributor who is performing better than expected, given that the antibiotic market is thriving.
  • The extensive pipeline including GLP-1 drugs is still at an early stage/midway through development, however at this valuation, you are probably not paying for it!

Pre-IPO B&K Corporation – Valuation Performance Could Be Disappointing

By Xinyao (Criss) Wang

  • The growth factor drug market is highly competitive. Many competing products have been on the market for many years with NRDL reimbursement coverage and also accumulated rich recognition from doctors/patients.
  • Even if Pro-101 is approved for market launch, B&K may have to reduce its price largely and invest heavily in market education/promotion. B&K’s commercialization capability still needs to be verified.
  • Valuation of B&K would be lower than peers. It is hard for B&K to receive expected valuation premium since its latest round of post investment valuation is already RMB3.3 billion.

Aldeyra Therapeutics Inc (ALDX) – Wednesday, Apr 10, 2024

By Value Investors Club

  • Mack885 identified buying opportunity in ALDX due to management’s plan to address FDA setback
  • Perceptive Advisors increased stake in anticipation of reproxalap approval for dry eye disease
  • Potential option agreement with AbbVie could greatly benefit ALDX financially, making its share price undervalued

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


SNGX: Positive Interim Results for HyBryte in Investigator-Initiated Study in CTCL Raising Valuation to 35

By Zacks Small Cap Research

  • On July 9, 2024, Soligenix, Inc. (SNGX) announced positive interim results for HyBryte in an open-label, investigator-initiated study in patients with early-stage cutaneous T cell lymphoma (CTCL).
  • Of the patients that have completed 12 weeks of therapy, 3 of 4 (75%) have achieved “Treatment Success”, which is defined as =50% improvement in their cumulative mCAILS (modified Composite Assessment of Index Lesion Severity).
  • Two patients have not reached their first efficacy evaluation visit (i.e., at Week 6) and the last patient had a substantial improvement documented by Week 18 but had not yet achieved the success threshold.

BCLI: Preparing to Initiate Phase 3b Trial of NurOwn Before End of 2024

By Zacks Small Cap Research

  • On July 8, 2024, BrainStorm Cell Therapeutics, Inc. (BCLI) conducted a mid-year conference call to provide an update on the status of the company’s NurOwn program.
  • During the call, the company reiterated that it is committed to conducting a Phase 3b trial of NurOwn in patients with amyotrophic lateral sclerosis (ALS) to support a potential Biologics License Application (BLA) filing.
  • BrainStorm has reached agreement with the FDA on a Special Protocol Assessment (SPA) and the CMC aspects of the upcoming Phase 3b trial.

AFT Pharmaceuticals – Continued execution of footprint expansion

By Edison Investment Research

AFT Pharmaceuticals continues to make inroads in expanding its strategic market footprint. Most recently, it announced the entry into China with the distribution of Crystaderm (approved by Chinese regulators in November 2023) through an agreement with Hainan Haiyao Co. We expect this to provide AFT with access to China’s offline retail and hospital segments, which represent roughly 75% of the country’s OTC market, a significant bump from AFT’s current Chinese e-commerce presence. This announcement comes on the heels of the news on Maxigesic Rapid securing a non-exclusive distribution partnership in the US with Alexso, a specialist distributor focused on non-opioid pain-management products. Given the notable size of both the US and Chinese markets, we expect these new market launches (both expected within CY24) to support top-line traction internationally.


Immix Biopharma – US CAR-T trial commences patient dosing

By Edison Investment Research

Immix has announced that the first patient has been dosed in its Phase Ib NEXICART-2 trial of lead CAR-T asset NXC-201, which took place at lead study site, the Memorial Sloan Kettering Cancer Center. This US-based study will evaluate the safety and efficacy of NXC-201 in approximately 40 patients with relapsed/refractory amyloid light chain amyloidosis (r/r ALA). Management expects the trial to be fully enrolled within 18 months, implying that top-line results could be available in H126. In the near term, we anticipate rolling data readouts as seen with the prior NEXICART-1 trial. We also expect more details for the expansion of NXC-201 into additional autoimmune indications by the end of 2024.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars